Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
ResMed Inc.’s CEO, Michael J. Farrell, has executed a series of stock transactions as part of a pre-planned trading arrangement. The transactions involved the acquisition and disposal of ResMed common stock, with significant movements including the sale of shares at a weighted average price of $246.259. These strategic moves reflect the executive’s engagement in managing his stock portfolio within the framework of regulatory guidelines.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
